MediFind
Condition

Fanconi Syndrome

Active Clinical Trials

Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 36
  • Start Date: June 9, 2020
A Phase II Study of Olaparib in Patients With Advanced Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations
Clinical Trial
Other
  • Status: Recruiting
  • Study Type: Other
  • Participants: 50
  • Start Date: April 5, 2019
A European, Multicenter, Prospective Clinical Study to Evaluate Cysteamine Toxicity on Human Osteoclasts. The CYSTEA-BONE Clinical Study.
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 55
  • Start Date: May 8, 2018
Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 24
  • Start Date: March 29, 2018
Pilot Study of Metformin for Patients With Fanconi Anemia
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 32
  • Start Date: July 2012
Quercetin in Children With Fanconi Anemia; a Pilot Study
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 750
  • Start Date: August 2010
Cure Cystinosis International Registry
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 25
  • Start Date: March 26, 2002
Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia MT2002-02